The short explanation
Tamoxifen can affect the lining of the womb and slightly increases the risk of endometrial hyperplasia and womb cancer, particularly in women after menopause. Spotting after menopause in a woman taking tamoxifen should always be reported to her doctor promptly. Many causes of spotting are benign, such as polyps or thinning of the vaginal lining. But because of the extra risk, doctors usually arrange an ultrasound and often a biopsy or hysteroscopy to check the lining.
What depends on your situation
The parts of this that change from woman to woman. Uncertainty is stated, not hidden.
- She should not stop tamoxifen on her own, as it is an important part of her breast cancer treatment. Her oncologist and gynaecologist can work together.
- Her doctors will also want to know about any discharge, pain, or changes in bladder or bowel habits.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot tell you the cause of her spotting. Only an examination and tests can show that.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Could this spotting be related to tamoxifen?
- What tests does she need to check the lining?
- Should her tamoxifen treatment change?
- How will the gynaecologist and oncologist share information?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Emergency — call 112 now
- Call 112 or go to the emergency department if she has heavy bleeding or feels faint.
Book an appointment soon
- Arrange a gynaecology appointment within one to two weeks for any bleeding after menopause.
Sources
The evidence this explanation is built on.
- Uterine cancer MedlinePlus (US National Library of Medicine)
- Uterine cancer National Cancer Institute
- Womb (uterus) cancer NHS
- Breast cancer MedlinePlus (NIH)
Who wrote and reviewed this
Every AskHer answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHer Editorial (AI-assisted) AskHer's editorial team — not an individual clinician Works in English, தமிழ், हिन्दी
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHer’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.

